LMNA variants often warrant early, more aggressive preventive measures such as preventative implantable cardioverter defibrillator (ICD) placement, whereas SCN5A-related DCM may benefit from close arrhythmia surveillance, early rhythm control, and assessment of reversibility. The gene discussed is SCN5A; the disease is cardiac arrhythmia.